100 WASHINGTON BOULEVARD, STAMFORD, CT
News, Articles of Incorporation, Bylaws
Shareholder votes
Other Events
To Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Q1
FY 2023
Q3
Q2
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
S-8 POS